LUNG THERAPEUTICS, INC.

Profile

Company Names

LUNG THERAPEUTICS, INC.

Addresses

3801 S. CAPITAL OF TX HWY, SUITE 330, AUSTIN, TX 78704

2600 VIA FORTUNA, SUITE 360, AUSTIN, TX 78746

2801 VIA FIORTUNA, SUITE 425, AUSTIN, TX 78746

4801 VIA FORTUNA, SUITE 425, AUSTIN, TX 78746

1515 S. CAPITAL OF TEXAS HWY, SUITE 402, AUSTIN, TX 78746

1250 S. CAPITAL OF TEXAS HWY, BUILDING 3, SUITE 434, AUSTIN, TX 78746

5703 MAGEE BEND, AUSTIN, TX 78749

Phone Numbers

737-802-1989
(737) 802-1973
(512) 809-8549
(512) 329-2420

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

TEXAS

Total Amount Raised:

$69,505,521.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2022-03-14 
$10,065,000.00 
$15,000,000.00 
$4,935,000.00 
Equity 
4
2019-05-20 
$38,682,750.00 
$38,682,750.00 
$0.00 
Equity 
3
2018-06-15 
$3,855,000.00 
$3,855,000.00 
$0.00 
 
2
2016-03-01 
$14,333,859.00 
$14,333,859.00 
$0.00 
Equity 
1
2014-09-05 
$2,568,912.00 
$2,568,912.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
C. 
FAIREY 
DIRECTOR
LUNG THERAPEUTICS, INC.   |  MIRUM PHARMACEUTICALS, INC.
AARON 
 
FLETCHER 
DIRECTOR
LUNG THERAPEUTICS, INC.   |  COGNITION THERAPEUTICS INC   |  BIOS LTI SPV II, LP   |  TFF PHARMACEUTICALS, INC.   |  ABILITECH MEDICAL, INC.   |  XY GAMING, INC.   |  CUE BIOPHARMA, INC.   |  BIOS SPECIAL OPPORTUNITY FUND II, LP   |  ACTUATE THERAPEUTICS, INC.   |  ONL THERAPEUTICS, INC.
AARON 
G.L. 
FLETCHER 
DIRECTOR
LUNG THERAPEUTICS, INC.   |  BIOS SPECIAL OPPORTUNITY FUND, LP   |  BIOS ACTUATE CO-INVEST III, LP   |  BIOS CLINICAL OPPORTUNITY FUND, LP   |  BIOS 2024 CO-INVEST, LP   |  BIOS ONL CO-INVEST II, LP   |  ACTUATE THERAPEUTICS, INC.
CHARLES 
 
GARNER 
EXECUTIVE OFFICER
RECRO PHARMA, INC.   |  LUNG THERAPEUTICS, INC.
STEVEN 
 
IDELL 
DIRECTOR
LUNG THERAPEUTICS, INC.
JIM 
 
MERVIS 
DIRECTOR
RASNA THERAPEUTICS INC.   |  LUNG THERAPEUTICS, INC.
ROBERT 
 
MILLS 
DIRECTOR
LUNG THERAPEUTICS, INC.   |  PEP OVATION, LP   |  MAXIMUM FIDELITY SURGICAL SIMULATIONS, INC.
R. 
A. 
SESSION 
DIRECTOR
LUNG THERAPEUTICS, INC.
BRIAN 
 
WINDSOR 
EXECUTIVE OFFICER, DIRECTOR
TFF PHARMACEUTICALS, INC.   |  LUNG THERAPEUTICS, INC.
JAMES 
BRIAN 
WINDSOR 
EXECUTIVE OFFICER, DIRECTOR
LUNG THERAPEUTICS, INC.
JOSEPH 
 
WOELKERS 
DIRECTOR
LUNG THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-04-04
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-03-14 
2019-10-31
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-20 
2019-05-24
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-05-20 
2018-07-26
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2018-06-15 
2017-05-19
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-01 
2017-02-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-01 
2016-03-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-01 
2015-09-30
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-05 
2014-09-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-09-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NEWBRIDGE SECURITIES CORPORATION
104065